Table 6.
National | Nairobi region | Central region | Coast region | |
---|---|---|---|---|
Saved costs (2018 US dollars) | ||||
Acute CVD care |
0.22 [0.19 to 0.24] billion |
16.94 [14.77 to 19.01] million |
40.70 [37.72 to 43.45] million |
15.85 [13.64 to 18.02] million |
Non‐acute CVD care |
0.15 [0.11 to 0.20] billion |
14.33 [10.43 to 18.56] million |
32.18 [26.82 to 37.56] million |
11.08 [7.02 to 18.02] million |
Additional costs (2018 US dollars) | ||||
ART |
1.18 [1.17 to 1.20] billion |
133.71 [132.20 to 135.16] million |
83.81 [82.45 to 85.13] million |
91.16 [89.83 to 92.51] million |
Diabetes treatment |
1.28 [1.27 to 1.29] billion |
211.9 [210.67 to 213.23] million |
207.46 [206.27 to 208.58] million |
84.18 [83.36 to 84.98] million |
Hypertension treatment | ||||
Screening for HIV |
603.34 [603.12 to 603.58] million |
62.03 [62.00 to 62.05] million |
67.63 [67.61 to 67.65] million |
50.56 [50.54 to 50.59] million |
Screening for diabetes and hypertension |
34.24 [34.22 to 34.25] million |
3,519.73 [3,521.09 to 3,518.35] thousand |
3,837.83 [3,839.01 to 3,836.62] thousand |
2,869.06 [2,870.42 to 2,867.70] thousand |
Total Costs (2018 US dollars) | ||||
Incremental costs |
6.68 [6.61 to 6.74] billion |
632.95 [626.79 to 638.75] million |
945.29 [937.44 to 93.05] million |
471.59 [466.08 to 476.99] million |
Total DALYs | ||||
Incremental DALYs averted |
7.76 [8.01 to 7.51] million |
839.13 [811.93 to 865.24] |
632.88 [608.74 to 657.06] |
576.82 [547.86 to 604.93] |
Incremental costs per DALY (2018 USD) | ||||
860.36 [830.59 to 890.66] |
754.04 [729.63 to 780.26] |
1,493.07 [1,435.63 to 1,555.65] |
818.01 [864.38 to 776.50] |
Non‐communicable diseases (NCD); Disability‐adjusted life year (DALY); Cardiovascular disease (CVD).
Values represent the differences in simulated costs and DALYs between the baseline and intervention at a national and regional level. Future costs are discounted at 3%. Values represents the median [95% uncertainty ranges] across 2,000 random simulations.